Dr. Pavan Reddy, director of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine, has been elected to ...
Large mergers and acquisitions in the Indian pharmaceutical market are unlikely soon due to various uncertainties, says GV ...
Dr. Reddy's Laboratories Ltd. closed 18.05% short of its 52-week high of 1,420.20 rupees, which the company achieved on ...
Dr. Gundu Reddy is a Board Certified Psychiatrist in New York City. Prior to starting residency at Mount Sinai School of medicine she pursued additional research in HIV psychiatry. As well as ...
Dr. Reddy's Laboratories, USA, a wholly owned subsidiary of the company, has successfully completed the sale of all issued ...
Dr. Reddy's Laboratories Ltd. closed 18.16% short of its 52-week high of 1,420.20 rupees, which the company achieved on August 21st.
Foundation & Chief Medical Officer of Strategy Prime Healthcare Dr Kavitha Bhatia Reddy, president and chair of the Prime ...
Dr. Reddy’s Laboratories (RDY) and Alvotech (ALVO) announced that the U.S. Food and Drug Administration, FDA, has accepted a 351(k) Biologic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results